{"id":17735,"date":"2015-09-10T00:00:00","date_gmt":"2015-09-10T00:00:00","guid":{"rendered":"https:\/\/cadca1stg.wpengine.com\/resource\/senators-call-for-investigation-into-fda-decision-on-oxycontin\/"},"modified":"2015-09-10T00:00:00","modified_gmt":"2015-09-10T00:00:00","slug":"senators-call-for-investigation-into-fda-decision-on-oxycontin","status":"publish","type":"resource","link":"https:\/\/www.cadca.org\/fr\/resource\/senators-call-for-investigation-into-fda-decision-on-oxycontin\/","title":{"rendered":"Les s\u00e9nateurs demandent une enqu\u00eate sur la d\u00e9cision de la FDA concernant l&#039;Oxycontin"},"content":{"rendered":"<p>Les s\u00e9nateurs Joe Manchin (DW.V.), Tim Kaine (D-Va.) et Mark Warner (D-Va.) ont envoy\u00e9 une lettre au pr\u00e9sident du comit\u00e9 de la sant\u00e9, de l&#039;\u00e9ducation, du travail et des retraites (HELP), Lamar Alexander (R-Tenn .) et Patty Murray (D-Wash.), membre du classement, appelant \u00e0 une enqu\u00eate sur la d\u00e9cision de la Food and Drug Administration (FDA) d&#039;approuver l&#039;utilisation d&#039;OxyContin par des enfants d\u00e8s l&#039;\u00e2ge de 11 ans et \u00e0 un examen de l&#039;augmentation du abus et abus d\u2019opio\u00efdes et d\u00e9c\u00e8s par surdose qui en r\u00e9sultent.<\/p>\n<p>&quot;La d\u00e9cision de la FDA de prescrire OxyContin \u00e0 des enfants d\u00e8s l&#039;\u00e2ge de 11 ans est un exemple horrible du d\u00e9calage entre le processus d&#039;approbation de l&#039;agence et les r\u00e9alit\u00e9s que l&#039;\u00e9pid\u00e9mie mortelle d&#039;abus de m\u00e9dicaments sur ordonnance a sur nos communaut\u00e9s&quot;, a d\u00e9clar\u00e9 Manchin. dans un communiqu\u00e9 de presse.<strong> <\/strong>\u00ab Le S\u00e9nat doit agir rapidement pour examiner cette d\u00e9cision, qui a \u00e9t\u00e9 prise sans l\u2019avis d\u2019un comit\u00e9 consultatif ind\u00e9pendant, et examiner plus largement l\u2019\u00e9pid\u00e9mie d\u2019abus d\u2019opio\u00efdes. \u00bb<\/p>\n<p>&quot;En ao\u00fbt, j&#039;ai voyag\u00e9 \u00e0 travers le Commonwealth et j&#039;ai entendu des dirigeants locaux, des forces de l&#039;ordre et des professionnels de la sant\u00e9 parler de l&#039;impact de l&#039;abus d&#039;opio\u00efdes sur nos communaut\u00e9s&quot;, a d\u00e9clar\u00e9 Kaine dans un communiqu\u00e9 de presse. \u00ab La prescription excessive et l&#039;usage abusif d&#039;opio\u00efdes ont contribu\u00e9 \u00e0 la crise de l&#039;abus de drogues, et je suis profond\u00e9ment pr\u00e9occup\u00e9 par le fait que la d\u00e9cision de la FDA d&#039;approuver l&#039;OxyContin pour les enfants \u00e2g\u00e9s d&#039;\u00e0 peine 11 ans complique encore davantage cette \u00e9pid\u00e9mie. \u00bb<\/p>\n<p>\u00ab L\u2019augmentation exponentielle de l\u2019abus d\u2019opio\u00efdes a un effet d\u00e9vastateur sur la Virginie et le reste du pays. Je suis troubl\u00e9 par la d\u00e9cision de la FDA d&#039;\u00e9largir la population approuv\u00e9e qui utilise ces drogues addictives pour inclure des enfants d\u00e8s l&#039;\u00e2ge de 11 ans. Je suis particuli\u00e8rement pr\u00e9occup\u00e9 par le fait que cette d\u00e9cision a \u00e9t\u00e9 prise sans l&#039;avis d&#039;un comit\u00e9 consultatif ind\u00e9pendant, comme l&#039;exige la r\u00e9glementation de la FDA dans des cas comme celui-ci.<strong> <\/strong>Warner a d\u00e9clar\u00e9 dans un communiqu\u00e9 de presse. \u00ab\u00a0Une enqu\u00eate approfondie assurera la responsabilit\u00e9 et la transparence sur la mani\u00e8re dont cette d\u00e9cision a \u00e9t\u00e9 prise.\u00a0\u00bb<\/p>\n<p>La lettre a \u00e9galement \u00e9t\u00e9 sign\u00e9e par les s\u00e9nateurs Jeanne Shaheen (DN.H.), Bill Nelson (D-Fla.), Ed Markey (D-Mass.), Kelly Ayotte (RN.H.), Angus King (I-Maine). et Claire McCaskill (D\u00e9mocrate du Missouri).<\/p>\n<p><strong>VOIR \u00c9GALEMENT:<\/strong><\/p>\n<p>Cours en ligne du CADCA\u00a0: \u00ab\u00a0Appliquer le cadre strat\u00e9gique de pr\u00e9vention \u00e0 l&#039;abus de m\u00e9dicaments sur ordonnance\u00a0\u00bb<\/p>\n<p>\u00a0<\/p>","protected":false},"excerpt":{"rendered":"<p>Senators Joe Manchin (D-W.V.), Tim Kaine (D-Va.) and Mark Warner (D-Va.) sent a letter to the Health, Education, Labor and<\/p>","protected":false},"author":23,"featured_media":0,"template":"","resource_type":[281],"drug_specific_issues":[307],"action_to_do":[],"class_list":["post-17735","resource","type-resource","status-publish","hentry","resource_type-coalitions-online","drug_specific_issues-prescription-and-over-the-counter-medications"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.9 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Senators Call for Investigation into FDA Decision on Oxycontin | CADCA<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.cadca.org\/fr\/resource\/senators-call-for-investigation-into-fda-decision-on-oxycontin\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Senators Call for Investigation into FDA Decision on Oxycontin | CADCA\" \/>\n<meta property=\"og:description\" content=\"Senators Joe Manchin (D-W.V.), Tim Kaine (D-Va.) and Mark Warner (D-Va.) sent a letter to the Health, Education, Labor and\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.cadca.org\/fr\/resource\/senators-call-for-investigation-into-fda-decision-on-oxycontin\/\" \/>\n<meta property=\"og:site_name\" content=\"CADCA\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.cadca.org\/wp-content\/uploads\/2022\/03\/cadca-member-of-logo1.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"880\" \/>\n\t<meta property=\"og:image:height\" content=\"500\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data1\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.cadca.org\\\/resource\\\/senators-call-for-investigation-into-fda-decision-on-oxycontin\\\/\",\"url\":\"https:\\\/\\\/www.cadca.org\\\/resource\\\/senators-call-for-investigation-into-fda-decision-on-oxycontin\\\/\",\"name\":\"Senators Call for Investigation into FDA Decision on Oxycontin | CADCA\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.cadca.org\\\/#website\"},\"datePublished\":\"2015-09-10T00:00:00+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.cadca.org\\\/resource\\\/senators-call-for-investigation-into-fda-decision-on-oxycontin\\\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.cadca.org\\\/resource\\\/senators-call-for-investigation-into-fda-decision-on-oxycontin\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.cadca.org\\\/resource\\\/senators-call-for-investigation-into-fda-decision-on-oxycontin\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.cadca.org\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Senators Call for Investigation into FDA Decision on Oxycontin\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.cadca.org\\\/#website\",\"url\":\"https:\\\/\\\/www.cadca.org\\\/\",\"name\":\"CADCA\",\"description\":\"The Premier Prevention Association\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.cadca.org\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Senators Call for Investigation into FDA Decision on Oxycontin | CADCA","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.cadca.org\/fr\/resource\/senators-call-for-investigation-into-fda-decision-on-oxycontin\/","og_locale":"fr_FR","og_type":"article","og_title":"Senators Call for Investigation into FDA Decision on Oxycontin | CADCA","og_description":"Senators Joe Manchin (D-W.V.), Tim Kaine (D-Va.) and Mark Warner (D-Va.) sent a letter to the Health, Education, Labor and","og_url":"https:\/\/www.cadca.org\/fr\/resource\/senators-call-for-investigation-into-fda-decision-on-oxycontin\/","og_site_name":"CADCA","og_image":[{"width":880,"height":500,"url":"https:\/\/www.cadca.org\/wp-content\/uploads\/2022\/03\/cadca-member-of-logo1.jpg","type":"image\/jpeg"}],"twitter_card":"summary_large_image","twitter_misc":{"Dur\u00e9e de lecture estim\u00e9e":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.cadca.org\/resource\/senators-call-for-investigation-into-fda-decision-on-oxycontin\/","url":"https:\/\/www.cadca.org\/resource\/senators-call-for-investigation-into-fda-decision-on-oxycontin\/","name":"Senators Call for Investigation into FDA Decision on Oxycontin | CADCA","isPartOf":{"@id":"https:\/\/www.cadca.org\/#website"},"datePublished":"2015-09-10T00:00:00+00:00","breadcrumb":{"@id":"https:\/\/www.cadca.org\/resource\/senators-call-for-investigation-into-fda-decision-on-oxycontin\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.cadca.org\/resource\/senators-call-for-investigation-into-fda-decision-on-oxycontin\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.cadca.org\/resource\/senators-call-for-investigation-into-fda-decision-on-oxycontin\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.cadca.org\/"},{"@type":"ListItem","position":2,"name":"Senators Call for Investigation into FDA Decision on Oxycontin"}]},{"@type":"WebSite","@id":"https:\/\/www.cadca.org\/#website","url":"https:\/\/www.cadca.org\/","name":"CADCA","description":"The Premier Prevention Association","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.cadca.org\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"}]}},"_links":{"self":[{"href":"https:\/\/www.cadca.org\/fr\/wp-json\/wp\/v2\/resource\/17735","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.cadca.org\/fr\/wp-json\/wp\/v2\/resource"}],"about":[{"href":"https:\/\/www.cadca.org\/fr\/wp-json\/wp\/v2\/types\/resource"}],"author":[{"embeddable":true,"href":"https:\/\/www.cadca.org\/fr\/wp-json\/wp\/v2\/users\/23"}],"version-history":[{"count":0,"href":"https:\/\/www.cadca.org\/fr\/wp-json\/wp\/v2\/resource\/17735\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.cadca.org\/fr\/wp-json\/wp\/v2\/media?parent=17735"}],"wp:term":[{"taxonomy":"resource_type","embeddable":true,"href":"https:\/\/www.cadca.org\/fr\/wp-json\/wp\/v2\/resource_type?post=17735"},{"taxonomy":"drug_specific_issues","embeddable":true,"href":"https:\/\/www.cadca.org\/fr\/wp-json\/wp\/v2\/drug_specific_issues?post=17735"},{"taxonomy":"action_to_do","embeddable":true,"href":"https:\/\/www.cadca.org\/fr\/wp-json\/wp\/v2\/action_to_do?post=17735"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}